Evidence map›Paper›PMID 42164871›Full record

ArticleOrganic process research & development2026

Frugal Sampling Strategies for Navigating Complex Reaction Spaces.

Vincent Porte, Luca Hepp, Philipp Kollmus, Shizhao Lu, Eloisa Serrano, Daniela Blanco, Marco Santagostino

Abstract read
In one paragraph

Article in Organic process research & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vincent PorteChemical Development Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß 88397, Germany.ORCID https://orcid.org/0000-0003-3156-2973
Luca HeppChemical Development Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß 88397, Germany.
Philipp KollmusChemical Development Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß 88397, Germany.
Shizhao LuSunthetics, Inc, 3055 Hunter Rd, San Marcos, Texas 78666, United States.ORCID https://orcid.org/0000-0003-3055-1877
Eloisa SerranoChemical Development Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß 88397, Germany.
Daniela BlancoSunthetics, Inc, 3055 Hunter Rd, San Marcos, Texas 78666, United States.
Marco SantagostinoChemical Development Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß 88397, Germany.ORCID https://orcid.org/0000-0002-7724-1641

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the complexity of the chemical space continues to grow, innovative strategies are required to enhance screening efficiency. With the main goal of identifying overarching trends, we introduce novel high-throughput experimentation (HTE) sampling strategies that explore broader chemical spaces and only require 25% of the experiments compared to full factorial designs. Our carefully designed quasi-random sampling methods maximize plate layout diversity while preserving practicality for 96-well microtiter plates. The frugal samplings were successfully applied to four challenging metal-catalyzed cross-coupling reactions. The resulting screens retained sufficient information to understand the main tendencies and enable informed decision-making for subsequent optimization activities. In one case study, the method was coupled with a Bayesian optimization workflow to enable cost-effective transformations within the explored chemical space by introducing a cost-penalized yield as an optimization objective.

Indexed as

Bayesian optimizationcross-couplingDoEfrugal samplingHTE

Identifiers

PMID42164871
PMCPMC13186068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.